96 related articles for article (PubMed ID: 28509590)
1. Health care costs associated with Australian tertiary inflammatory bowel disease care.
Jackson B; Con D; Ma R; Gorelik A; Liew D; De Cruz P
Scand J Gastroenterol; 2017 Aug; 52(8):851-856. PubMed ID: 28509590
[TBL] [Abstract][Full Text] [Related]
2. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
Park KT; Ehrlich OG; Allen JI; Meadows P; Szigethy EM; Henrichsen K; Kim SC; Lawton RC; Murphy SM; Regueiro M; Rubin DT; Engel-Nitz NM; Heller CA
Inflamm Bowel Dis; 2020 Jan; 26(1):1-10. PubMed ID: 31112238
[TBL] [Abstract][Full Text] [Related]
3. Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn's Disease in Italy.
Dovizio M; Hartz S; Buzzoni C; Redondo I; Nedeljkovic Protic M; Birra D; Perrone V; Veronesi C; Degli Esposti L; Armuzzi A
Adv Ther; 2024 Jun; 41(6):2282-2298. PubMed ID: 38619721
[TBL] [Abstract][Full Text] [Related]
4. Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study.
Bassi A; Dodd S; Williamson P; Bodger K
Gut; 2004 Oct; 53(10):1471-8. PubMed ID: 15361497
[TBL] [Abstract][Full Text] [Related]
5. Savings in social expenditures for work incapacity in patients with inflammatory bowel disease depend on access to innovative therapies in Poland.
Zagórowicz E; Binowski G; Strządała D; Pruszko C; Kucha P; Reguła J
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):695-703. PubMed ID: 38526938
[TBL] [Abstract][Full Text] [Related]
6. Financial toxicity among patients undergoing resectional surgery for inflammatory bowel disease in the United States.
Lee Y; Anvari S; Padoan A; McKechnie T; Park L; Doumouras AG; Eskicioglu C; Hong D
Colorectal Dis; 2024 Apr; 26(4):692-701. PubMed ID: 38353528
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, Indirect Costs, and Risk Factors for Work Disability in Patients with Crohn's Disease at a Tertiary Care Center in Rio de Janeiro.
de Sá Brito Fróes R; da Luz Moreira A; Carneiro AJV; Moreira JPL; Luiz RR; de Barros Moreira AMH; Monnerat CC; de Souza HSP; Carvalho ATP
Dig Dis Sci; 2021 Sep; 66(9):2925-2934. PubMed ID: 33044678
[TBL] [Abstract][Full Text] [Related]
8. Variation Between Hospitals in Outcomes and Costs of IBD Care: Results From the IBD Value Study.
van Linschoten RCA; van der Woude CJ; Visser E; van Leeuwen N; Bodelier AGL; Fitzpatrick C; de Jonge V; Vermeulen H; Verweij KE; van der Wiel S; Nieboer D; Birnie E; van der Horst D; Hazelzet JA; van Noord D; West RL
Inflamm Bowel Dis; 2024 Apr; ():. PubMed ID: 38666643
[TBL] [Abstract][Full Text] [Related]
9. Dietary Therapy With the Crohn's Disease Exclusion Diet is a Successful Strategy for Induction of Remission in Children and Adults Failing Biological Therapy.
Sigall Boneh R; Sarbagili Shabat C; Yanai H; Chermesh I; Ben Avraham S; Boaz M; Levine A
J Crohns Colitis; 2017 Oct; 11(10):1205-1212. PubMed ID: 28525622
[TBL] [Abstract][Full Text] [Related]
10. TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota.
Ihara S; Hirata Y; Koike K
J Gastroenterol; 2017 Jul; 52(7):777-787. PubMed ID: 28534191
[TBL] [Abstract][Full Text] [Related]
11. Ustekinumab: A Review in Moderate to Severe Crohn's Disease.
Lamb YN; Duggan ST
Drugs; 2017 Jul; 77(10):1105-1114. PubMed ID: 28528528
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease.
Valer P; Algaba A; Santos D; Fuentes ME; Nieto E; Gisbert JP; López P; Quintanilla E; García-Alonso FJ; Guerra I; Páez Á; Bermejo F
Inflamm Bowel Dis; 2017 Jul; 23(7):1144-1153. PubMed ID: 28520588
[TBL] [Abstract][Full Text] [Related]
13. Beyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease.
Olpin JD; Sjoberg BP; Stilwill SE; Jensen LE; Rezvani M; Shaaban AM
Radiographics; 2017; 37(4):1135-1160. PubMed ID: 28548906
[TBL] [Abstract][Full Text] [Related]
14. Towards therapeutic choices in ulcerative colitis.
Laharie D
Lancet; 2017 Jul; 390(10090):98-99. PubMed ID: 28527707
[No Abstract] [Full Text] [Related]
15. Interleukin-17 inhibition: role in psoriasis and inflammatory bowel disease.
Hohenberger M; Cardwell LA; Oussedik E; Feldman SR
J Dermatolog Treat; 2018 Feb; 29(1):13-18. PubMed ID: 28521565
[TBL] [Abstract][Full Text] [Related]
16. Exposure to oral contraceptives increases the risk for development of inflammatory bowel disease: a meta-analysis of case-controlled and cohort studies.
Ortizo R; Lee SY; Nguyen ET; Jamal MM; Bechtold MM; Nguyen DL
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1064-1070. PubMed ID: 28542115
[TBL] [Abstract][Full Text] [Related]
17. Immune Checkpoint Inhibitor-Induced Colitis: Diagnosis and Management.
Prieux-Klotz C; Dior M; Damotte D; Dreanic J; Brieau B; Brezault C; Abitbol V; Chaussade S; Coriat R
Target Oncol; 2017 Jun; 12(3):301-308. PubMed ID: 28540478
[TBL] [Abstract][Full Text] [Related]
18. A Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Vedolizumab.
Rosario M; Dirks NL; Milch C; Parikh A; Bargfrede M; Wyant T; Fedyk E; Fox I
Clin Pharmacokinet; 2017 Nov; 56(11):1287-1301. PubMed ID: 28523450
[TBL] [Abstract][Full Text] [Related]
19. Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.
Borren NZ; Conway G; Tan W; Andrews E; Garber JJ; Yajnik V; Ananthakrishnan AN
Inflamm Bowel Dis; 2017 Jul; 23(7):1234-1239. PubMed ID: 28520589
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
